Loading: 100%
STRYKER CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Kalamazoo, United States of AmericaKalamazoo, United States of Americano data available
Employees 33,000 (as per Q1 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker SYKno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17100,0112,5125,0137,5150,0
datesClosing price (adj.)
13.10.2017146.69
11.10.2017146.41
04.10.2017145.97
27.09.2017140.54
20.09.2017142.28
13.09.2017142.60
06.09.2017140.69
30.08.2017138.91
23.08.2017137.94
16.08.2017146.96
09.08.2017144.74
02.08.2017144.70
26.07.2017145.31
19.07.2017145.78
12.07.2017143.92
05.07.2017139.32
27.06.2017138.75
20.06.2017140.13
13.06.2017140.33
06.06.2017143.18
30.05.2017141.12
23.05.2017139.05
16.05.2017133.96
09.05.2017134.05
02.05.2017135.35
25.04.2017134.87
18.04.2017130.12
11.04.2017129.80
04.04.2017130.62
28.03.2017131.47
21.03.2017131.16
14.03.2017129.76
07.03.2017127.95
28.02.2017127.37
21.02.2017125.99
14.02.2017124.10
07.02.2017121.38
31.01.2017122.39
24.01.2017120.38
17.01.2017121.42
10.01.2017120.77
03.01.2017118.33
27.12.2016119.31
19.12.2016117.30
12.12.2016116.08
05.12.2016110.58
28.11.2016111.51
21.11.2016110.05
14.11.2016105.32
07.11.2016118.16
31.10.2016113.88
24.10.2016113.27
17.10.2016112.12
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
146.69n/a
Market Capitalisation
in million USD
54,828n/a
Enterprise Value
in million USD
58,654n/a
Common Shares Outstanding
as per Mar 31, 2017
373,765,028n/a
Preferred Shares Outstanding
as per Mar 31, 2017
n/a
Average Basic Shares Outstanding
TTM
374,150,000n/a
Average Diluted Shares Outstanding
TTM
378,975,000n/a
Index Membership
n/a
Business Summary
Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 10,883n/a
Gross Profit 7,229n/a
Operating Income 2,237n/a
EBITDA 2,452n/a
Net Profit 1,659n/a
Balance Sheet
Cash and Cash Equivalents 3,022n/a
Receivables 1,803n/a
Total Current Assets 7,366n/a
PP&E 1,505n/a
Total Assets 20,187n/a
Accounts Payable 420n/a
Current Debt 135n/a
Total Current Liabilities 3,026n/a
Long-Term Debt 6,713n/a
Total Liabilities 10,855n/a
Total Equity 9,332n/a
Cash Flow
Depreciation & Amortisation 215n/a
Change in Working Capital -454n/a
Operating Cash Flow 1,835n/a
Net Change in PP&E and Intangibles -426n/a
Investing Cash Flow -4,599n/a
Dividends Paid -556n/a
Financing Cash Flow 2,564n/a
Total Change in Cash -210n/a
Free Cash Flow 1,286n/a
Profitability Ratios
Gross Margin 66.4%n/a
Operating Margin 20.5%n/a
Net Profit Margin 15.2%n/a
Return on Equity 17.8%n/a
Return on Assets 8.2%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 23.92n/a
EV/Sales 5.39n/a
Book to Market Value 0.17n/a
Other Ratios
Current Ratio 243.4%n/a
Liabilities to Equity Ratio 116.3%n/a
Debt to Assets Ratio 33.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
6,001
6,718
6,723
7,320
8,307
8,657
9,021
9,675
9,946
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-1,865
-2,131
-2,184
-2,286
-2,811
-2,781
-3,002
-3,319
-3,344
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
4,135
4,587
4,539
5,034
5,496
5,876
6,019
6,356
6,602
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-2,808
-3,033
-2,878
-3,159
-3,734
-3,961
-4,141
-4,349
-4,445
Selling, General & Administrative
-2,392
-2,625
-2,506
-2,707
-3,150
-3,367
-3,467
-3,547
-3,610
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-375
-368
-336
-394
-462
-471
-536
-614
-625
Depreciation & Amortization
-41
-40
-36
-58
-122
-123
-138
-188
-210
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
1,327
1,554
1,661
1,875
1,762
1,915
1,878
2,007
2,157
Non-Operating Income (Loss)
63
61
30
-22
0
-36
-44
-86
-126
Interest Expense, net
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
63
61
30
-22
0
-36
-44
-86
-126
Pretax Income (Loss), Adjusted
1,390
1,615
1,691
1,853
1,762
1,879
1,834
1,921
2,031
Abnormal Gains (Losses)
-20
-35
-67
-124
-76
-174
-622
-761
-296
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
1,370
1,580
1,624
1,729
1,686
1,705
1,212
1,160
1,735
Income Tax (Expense) Benefit, net
-383
-432
-517
-456
-341
-407
-206
-645
-296
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
987
1,148
1,107
1,273
1,345
1,298
1,006
515
1,439
Net Extraordinary Gains (Losses)
31
0
0
0
0
0
0
0
0
Discontinued Operations
31
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
1,017
1,148
1,107
1,273
1,345
1,298
1,006
515
1,439
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
1,017
1,148
1,107
1,273
1,345
1,298
1,006
515
1,439
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
1,017
1,148
1,107
1,273
1,345
1,298
1,006
515
1,439
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 13, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 13, 2014 n/a
calculated values,
restated on Feb 12, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
2,196
2,955
4,380
3,418
4,285
3,980
5,000
4,079
Cash & Cash Equivalents
n/a
701
659
1,758
905
1,395
1,339
1,795
3,379
Short Term Investments
n/a
1,495
2,296
2,622
2,513
2,890
2,641
3,205
700
Accounts & Notes Receivable
n/a
1,130
1,147
1,252
1,417
1,430
1,518
1,572
1,662
Accounts Receivable, Net
n/a
1,130
1,147
1,252
1,417
1,430
1,518
1,572
1,662
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
953
943
1,057
1,283
1,265
1,422
1,588
1,639
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
702
806
943
1,089
1,168
1,415
524
563
Prepaid Expenses
n/a
180
204
290
312
357
535
524
563
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
522
602
653
777
811
880
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
4,979
5,851
7,632
7,207
8,148
8,335
8,684
7,943
Property, Plant & Equipment, Net
n/a
964
948
798
888
948
1,081
1,098
1,199
Property, Plant & Equipment
n/a
1,871
1,964
1,850
2,055
2,232
2,497
2,597
2,730
Accumulated Depreciation
n/a
-907
-1,016
-1,052
-1,167
-1,284
-1,416
-1,499
-1,531
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
1,660
2,273
2,465
4,051
4,110
6,327
7,497
7,081
Intangible Assets
n/a
0
0
0
0
0
0
0
0
Goodwill
n/a
568
957
1,072
2,072
2,142
3,844
4,186
4,136
Other Intangible Assets
n/a
368
635
703
1,442
1,424
1,989
2,018
1,794
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
212
259
248
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
513
422
442
537
544
494
1,293
1,151
Total Noncurrent Assets
n/a
2,624
3,220
3,263
4,939
5,058
7,408
8,595
8,280
Total Assets
n/a
7,603
9,071
10,895
12,146
13,206
15,743
17,279
16,223
Liabilities and owners' equity
Payables & Accruals
n/a
800 799700000
749 748700000
827 827000000
1,025 1025000000
926 926000000
1,867 1867000000
2,983 2983000000
2,024 2024000000
Accounts Payable
n/a
274 274300000
200 200200000
292 292000000
345 345000000
288 288000000
314 314000000
329 329000000
410 410000000
Accrued Taxes
n/a
30 30000000
135 134700000
47 47000000
155 155000000
70 70000000
131 131000000
333 333000000
141 141000000
Interest & Dividends Payable
n/a
159 158600000
60 59700000
70 70000000
81 81000000
101 101000000
115 115000000
131 131000000
142 142000000
Other Payables & Accruals
n/a
337 336800000
354 354100000
418 418000000
444 444000000
467 467000000
1,307 1307000000
2,190 2190000000
1,331 1331000000
Short Term Debt
n/a
21 20500000
18 18000000
25 25000000
17 17000000
16 16000000
25 25000000
727 727000000
768 768000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
642 641900000
674 674300000
753 753000000
798 798000000
934 934000000
765 765000000
751 751000000
710 710000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
642 641900000
674 674300000
753 753000000
798 798000000
934 934000000
765 765000000
751 751000000
710 710000000
Total Current Liabilities
n/a
1,462 1462100000
1,441 1441000000
1,605 1605000000
1,840 1840000000
1,876 1876000000
2,657 2657000000
4,461 4461000000
3,502 3502000000
Long Term Debt
n/a
0 0
0 0
996 996000000
1,751 1751000000
1,746 1746000000
2,739 2739000000
3,246 3246000000
3,230 3230000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
735 734500000
1,035 1035200000
1,120 1120000000
872 872000000
987 987000000
1,300 1300000000
977 977000000
980 980000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
735 734500000
1,035 1035200000
1,120 1120000000
872 872000000
987 987000000
1,300 1300000000
977 977000000
980 980000000
Total Noncurrent Liabilities
n/a
735 734500000
1,035 1035200000
2,116 2116000000
2,623 2623000000
2,733 2733000000
4,039 4039000000
4,223 4223000000
4,210 4210000000
Total Liabilities
n/a
2,197 2196600000
2,476 2476200000
3,721 3721000000
4,463 4463000000
4,609 4609000000
6,696 6696000000
8,684 8684000000
7,712 7712000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
852 852400000
940 939700000
1,003 1003000000
1,060 1060000000
1,136 1136000000
1,198 1198000000
1,290 1290000000
1,358 1358000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
4,390 4389500000
5,397 5397400000
6,017 6017000000
6,479 6479000000
7,332 7332000000
7,617 7617000000
7,559 7559000000
7,792 7792000000
Other Equity
n/a
165 164800000
258 258000000
154 154000000
144 144000000
129 129000000
232 232000000
-254 -254000000
-639 -639000000
Equity Before Minority Interest
n/a
5,407 5406700000
6,595 6595100000
7,174 7174000000
7,683 7683000000
8,597 8597000000
9,047 9047000000
8,595 8595000000
8,511 8511000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
5,407 5406700000
6,595 6595100000
7,174 7174000000
7,683 7683000000
8,597 8597000000
9,047 9047000000
8,595 8595000000
8,511 8511000000
Total Liabilities & Equity
n/a
7,603 7603300000
9,071 9071300000
10,895 10895000000
12,146 12146000000
13,206 13206000000
15,743 15743000000
17,279 17279000000
16,223 16223000000
Remarks restated on n/a restated on Feb 26, 2010 n/a restated on Feb 18, 2011 n/a restated on Feb 13, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 13, 2014 n/a restated on Feb 12, 2015 n/a restated on Feb 11, 2016 n/a restated on Oct 28, 2016 n/a
Cash Flow StatementCF data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
1,999
1,148
1,107
1,273
1,345
1,298
1,006
515
1,439
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
137
155
165
165
160
154
169
190
187
Non-Cash Items
163
336
229
154
252
348
881
1,194
-467
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-274
-463
-40
-45
-323
-143
-170
-117
-260
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
-10
0
0
0
0
0
0
0
0
Cash from Operating Activities
2,015
1,176
1,461
1,547
1,434
1,657
1,886
1,782
899
Change in Fixed Assets & Intangibles
-187
-147
-130
-121
-159
-210
-195
-233
-270
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-1,080
471
-628
-409
90
-372
298
-729
2,379
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
90
-14
-570
-265
-2,066
-154
-2,320
-916
-153
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
-2
0
0
0
0
0
0
0
0
Cash from Investing Activities
-1,178
310
-1,328
-795
-2,135
-736
-2,217
-1,878
1,956
Dividends Paid
-90
-136
-198
-238
-279
-324
-401
-462
-521
Cash From (Repayment of) Debt
1
7
-3
1,015
737
-4
1,005
1,159
48
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
70
-950
0
-426
-622
-108
-317
-100
-700
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
33
33
8
59
3
-13
13
32
32
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
14
-1,046
-193
410
-161
-449
300
629
-1,141
Net Cash Before Disc. Operations and FX
850
440
-60
1,162
-862
472
-31
533
1,714
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
850
440
-60
1,162
-862
472
-31
533
1,714
Effect of Foreign Exchange Rates
10
-29
18
-63
9
18
-25
-77
-130
Net Changes in Cash
861
411
-42
1,099
-853
490
-56
456
1,584
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 13, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 13, 2014 n/a
calculated values,
restated on Feb 12, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo